Factors associated with HPV vaccine use among Hispanic college students.

J Allied Health

701 W Grace St, Suite 2100, Box 843057, Richmond, VA 23284-3057, USA. Tel 804-828-9104, fax 804- 828-5778.

Published: November 2017

Unlabelled: Human papillomavirus (HPV) infection is the most common sexually transmitted disease in the United States and is linked strongly to cervical cancer. Hispanic women are at increased risk of cervical cancer from HPV due to lower screening rates with women in their early 20s at increased risk.

Purpose: The purpose of this project was to describe HPV vaccination rates and possible barriers to vaccination among a sample of U.S. collegeaged Hispanic women.

Methods: A secondary analysis of the American College Health Association's National College Health Assessment was completed to determine HPV vaccine rates and factors influencing vaccine use among college-aged Hispanic women (n=4,718). Descriptive statistics were calculated and binary logistic regression employed to determine the association of various socioeconomic and health-seeking behaviors on HPV vaccine utilization.

Results: Only 46.2% of Hispanic women in the NCHA reported receiving an HPV vaccine. Binary logistic regression analysis indicates that having health insurance, use of preventive care, and good health status are significantly associated with HPV vaccine use.

Discussion: Hispanic college women ages 18-26 demonstrated lower HPV vaccination rates as compared to Caucasian women. Tailoring health promotion activities to specific racial populations such as Hispanic women is necessary to decrease disparities in HPV vaccination rates. The fact that racial/ethnic minority women in the U.S. have lower HPV vaccination rates and gynecological exam rates indicates that specialized health promotion activities may be an avenue for designing educational strategies to lessen disparities.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hpv vaccine
20
hispanic women
16
hpv vaccination
16
vaccination rates
16
hpv
11
associated hpv
8
hispanic college
8
cervical cancer
8
women
8
college health
8

Similar Publications

Background: Vaccination against HPV is an effective strategy for the prevention of HPV infection and cervical cancer. Nevertheless, the HPV vaccine uptake rate is low among ethnic minorities in Hong Kong. This study sought to assess the feasibility and acceptability of motivational interviewing among South Asian mother-daughter dyads and to preliminarily examine its effects on knowledge of HPV infection and vaccination, health beliefs, intention to have the daughters vaccinated, and initiation and completion of HPV vaccine series.

View Article and Find Full Text PDF

Human Papillomavirus Vaccination at Age 9: Developments and Opportunities in the Field.

Acad Pediatr

January 2025

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive, Chapel Hill, NC 27599; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

View Article and Find Full Text PDF

Computational approaches of modelling human papillomavirus transmission and prevention strategies: a systematic review.

J Biol Dyn

December 2025

Modelling and Simulation Research Group, School of Computer Science, Faculty of Engineering, The University of Sydney, Sydney, NSW, Australia.

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the world. Persistent oncogenic HPV infection has been a leading threat to global health and can lead to serious complications such as cervical cancer. Prevention interventions including vaccination and screening have been proven effective in reducing the risk of HPV-related diseases.

View Article and Find Full Text PDF

Background: In an interim analysis of this phase 2 trial, adding the GX-188E vaccine to pembrolizumab resulted in manageable toxicity with antitumor activities in patients with recurrent or advanced cervical cancer. Here, we report the final safety and efficacy results after a long-term follow-up at the study's completion.

Methods: This open-label, single-arm, phase II trial was conducted in nine hospitals in South Korea (ClinicalTrials.

View Article and Find Full Text PDF

Optimized circular RNA vaccines for superior cancer immunotherapy.

Theranostics

January 2025

Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.

Circular RNA (circRNA) has gained attention as a promising platform for mRNA vaccines due to its stability, sustained protein expression, and intrinsic immunostimulatory properties. This study aimed to design and optimize a circRNA cancer vaccine platform by screening for efficient internal ribosome entry sites (IRES) and enhancing circRNA translation efficiency for improved cancer immunotherapy. We screened 29 IRES elements to identify the most efficient one for immune cell translation, ultimately discovering the A (EV-A) IRES.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!